at long last some good, page-7

Well they could always try to improve the stock price again by doing another capital consolidation. Who takes any notice anyway?

If the article in the current issue of "The New Investor" (Mar 2004 ) pp 67-68, is anything to go by.
Under the article "True Blue biotechs bounce back" - ''In a wider market several other small caps perfomed strongly, including ... and Australian Vaccine Technologies which jumped 950% from a low of $0.02 '' !

I wish!